Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed to perform home infusion include the drug (antivirals, immune globulin), equipment (a pump), and supplies (tubing and catheters). The home infusion process typically requires coordination among multiple entities, including patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if applicable, home health agencies.
Fresenius Kabi AG and Baxter International Inc – Notable Market Players in Home Infusion Therapy Market
The home infusion therapy market comprises top players such as B. Braun Melsungen AG, Micrel Medical Devices SA, Baxter International Inc, Nipro Corp, Becton Dickinson and Co, Fresenius Kabi AG, ICU Medical Inc, JMS Co Ltd, Eitan Medical Ltd, and Terumo Corp.
The companies listed above are implementing various strategies that have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the home infusion therapy market
|
Year |
News |
|
Nov-2022 |
Fresenius Kabi inaugurated its 4th MedTech manufacturing facility at Parque Industrial Itabo (PIISA) in Haina, Dominican Republic. This new facility will add around 12,000 m² (~130,000 sqf) to the Fresenius Kabi MedTech footprint in Haina and is projected to add 700 to the current 4,600 employees. The state-of-the-art manufacturing will have automated assembly lines, installations, clean rooms, and laboratories needed to manufacture and develop disposables such as infusion pump sets and plasma collection. |
|
Aug-2022 |
Baxter International Inc announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its new Novum I.Q. syringe infusion pump (SYR) with Dose IQ Safety Software, representing Baxter’s latest developments for infusion therapy. The Novum IQ SYR can fully integrate with hospital electronic medical records (EMRs) through Baxter’s I.Q. Enterprise Connectivity Suite. |
|
May-2022 |
Fresenius Kabi completed the acquisition of Ivenix, a manufacturer of infusion systems. Fresenius Kabi now offers healthcare professionals in the United States a broad and expanding portfolio of advanced infusion pumps and solutions to meet needs across the continuum of care |
